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We have previously shown that Epstein-Barr virus (EBV)-encoded dUTPase can modulate
innate immune responses through the activation of TLR2 and NF-κB signaling. However,
whether this novel immune function of the dUTPase is specific for EBV or a common
property of the Herpesviridae family is not known. In this study, we demonstrate that
the purified viral dUTPases encoded by herpes simplex virus type 2 (HSV-2), human
herpesvirus-6A (HHV-6A), human herpesvirus-8 (HHV-8) and varicella-zoster virus (VZV)
differentially activate NF-κB through ligation of TLR2/TLR1 heterodimers. Furthermore,
activation of NF-κB by the viral dUTPases was inhibited by anti-TLR2 blocking antibodies
(Abs) and the over-expression of dominant-negative constructs of TLR2, lacking the TIR
domain, and MyD88 in human embryonic kidney 293 cells expressing TLR2/TLR1. In
addition, treatment of human dendritic cells and PBMCs with the herpesviruses-encoded
dUTPases from HSV-2, HHV-6A, HHV-8, and VZV resulted in the secretion of the
inflammatory cytokines IL-1β, IL-6, IL-8, IL-12, TNF-α, IL-10, and IFN-γ. Interestingly,
blocking experiments revealed that the anti-TLR2 Ab significantly reduced the secretion
of cytokines by the various herpesviruses-encoded dUTPases (p < 0.05). To our
knowledge, this is the first report demonstrating that a non-structural protein encoded by
herpesviruses HHV-6A, HHV-8, VZV and to a lesser extent HSV-2 is a pathogen-associated
molecular pattern. Our results reveal a novel function of the virus-encoded dUTPases,
which may be important to the pathophysiology of diseases caused by these viruses. More
importantly, this study demonstrates that the immunomodulatory functions of dUTPases
are a common property of the Herpesviridae family and thus, the dUTPase could be a
potential target for the development of novel therapeutic agents against infections caused
by these herpesviruses.
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INTRODUCTION
The innate immune response is an early line of defense that
is essential for the detection of viruses. Cells contain a variety
of sensors referred to as pattern recognition receptors (PRRs)
that detect pathogen associated molecular patterns (PAMPs). The
primary PRRs recognizing virus PAMPs include the retinoic acid-
inducible gene 1 (RIG-I)-like receptors (RLR), the nucleotide
oligomerization domain (NOD)-like receptors (NLRs) and the
Toll-like receptors (TLRs) (Kawai and Akira, 2006; Gilliet et al.,
2008). Monocytes/macrophages and dendritic cells (DCs) are
professional antigen presenting cells (APCs) and play an impor-
tant role in regulating the balance between tolerance and immune
responses that initiate innate and adaptive immunity. There is
accumulating evidence demonstrating that human herpesviruses
infect monocytes, macrophages and DCs resulting in non-
productive, productive or latent infections (Kondo et al., 1991;
Blasig et al., 1997; Hahn et al., 1998; Savard et al., 2000; Abendroth
et al., 2001; Mikloska et al., 2001; Zhang et al., 2001; Kakimoto
et al., 2002; Li et al., 2002; Morrow et al., 2003; Senechal et al.,
2004; Smith et al., 2005; Rappocciolo et al., 2006; Walling et al.,
2007; Goldwich et al., 2011; Wang et al., 2012), and alter their
functions (Kruse et al., 2000; Niiya et al., 2004; West et al.,
2011; Gregory et al., 2012; Gustafsson et al., 2013; Stefanidou
et al., 2013). However, the mechanism(s) by which human her-
pesviruses alter macrophage/DC function is unclear. Likewise,
studies to determine the mechanism(s) by which the innate
immune system is activated by herpesviruses have focused pri-
marily on the intracellular recognition pathway for the CG rich
DNA of these viruses or on the extracellular recognition of a viral-
encoded structural protein(s) by TLR2 (Compton et al., 2003;
Kurt-Jones et al., 2004; Aravalli et al., 2005; Wang et al., 2005;
Boehme et al., 2006; Sato et al., 2006; Gaudreault et al., 2007;
Paludan et al., 2011; Cal et al., 2012; Leoni et al., 2012). However,
to the best of our knowledge there have not been any studies
to determine whether non-structural proteins encoded by the
human herpesviruses act as PAMPs and alter DC function.
www.frontiersin.org September 2014 | Volume 5 | Article 504 | 1
Ariza et al. Herpesviruses-encoded dUTPases and immune dysfunction
The Herpesviridae family, which contains several members
that are pathogenic for humans, are divided into three sub-
families (α, β, and γ) based upon their cellular tropism and
genomic structure. Viruses from the three subfamilies contain
a subset of genes that by criteria of genomic position and sim-
ilarities in encoded amino acids sequences are common to all
members. One such gene encodes for a deoxyuridine triphos-
phate nucleotidohydrolase (dUTPase). dUTPases represent a fam-
ily of metalloenzymes that catalyze the hydrolysis of dUTP to
dUMP and pyrophosphate (Nyman, 2001). dUTPases are divided
into three subgroups based upon their structure and speci-
ficity for dUTP. The monomeric dUTPases, which are thought
to have arisen from the trimeric dUTPases by gene duplica-
tion (Baldo and McClure, 1999), are found exclusively in her-
pesviruses (McGeehan et al., 2001). We have recently shown
that the Epstein-Barr virus (EBV)-encoded dUTPase, which is
an early protein expressed during lytic/abortive-lytic replication
of the virus, possesses novel functions in innate immunity due
in part to the activation of toll-like receptor TLR2 and sub-
sequent modulation of downstream genes involved in type I
interferon (IFNα/β) and cytokine/chemokine receptor signaling
pathways (Glaser et al., 2006; Waldman et al., 2008; Ariza et al.,
2009, 2013). While the members of the human herpesvirus fam-
ily have considerable diversity with respect to cellular tropism
and pathogenesis, they all encode for putative dUTPases, sug-
gesting that these proteins may be critical to the biology of these
viruses. Furthermore, it is important to understand what virus-
encoded macromolecules have the potential to modulate the
innate and adaptive immune systems. In this report, we provide
compelling evidence demonstrating that the immune modula-
tory properties of the monomeric dUTPases are not restricted to
EBV, but rather it is a property of several members of the human
herpesviruses.
MATERIALS AND METHODS
REAGENTS
The NF-κB luciferase promoter construct pNF-κB-Luc and the
transfection control reporter vector pRL-TK, were purchased
from Clontech Laboratories, Inc., (Mountain View, CA), and
Promega (Madison, WI), respectively. Wild-type pCMV-TLR1
vector was a gift from Dr Koichi Kuwano (Kurume University
School of Medicine, Kurume, Japan). pCMV-MyD88DN expres-
sion construct was a gift from Dr. Jason A. Boch (Department
of Medicine, Harvard Medical School, Boston, MA). Dominant-
negative pZero-hTLR2 expression plasmid, puromycin, blasti-
cidin, zymosan, FSL-1, and Pam3Csk4 were purchased from
Invivogen (San Diego, California). IgG2a Isotype control mon-
oclonal antibody was purchased from eBioscience (San Diego,
California) and anti-TLR2 (clone TL2.1) monoclonal antibody
was purchased from Imgenex (San Diego, California).
CLONING OF THE HERPESVIRUSES dUTPases
Subcloning of the dUTPase genes from human herpesvirus-
6A (HHV-6A, U45; kindly provided by Dr. Dharam Ablashi,
HHV-6 Foundation), human herpesvirus-8 (HHV-8, ORF54;
clone L54, which was obtained through the NIH AIDS Reagent
Program, Division of AIDS, NIAID, NIH from Drs. Patrick
Moore and Yan Chang), herpes simplex virus 2 (HSV-2, UL50;
pGEM-HSV2dUT; kindly provided by Dr. Salvatore Caradonna,
Rowan University), varicella-zoster virus (VZV, ORF8) (Ross
et al., 1997), as well as subcloning of the human dUTPase
(kindly provided by Dr. Evan McIntosh) (McIntosh et al., 1992)
was conducted by PCR amplification using the forward and
reverse primer sets (125 pmol of each) specific for each gene,
DNA (140 ng), high fidelity PCR supermix (Invitrogen) and the
following PCR conditions: Denaturation at 94◦C for 3min (′) (1
cycle) followed by 35 cycles of 94◦C for 30 s (sec), 50◦C for 30 s,
72◦C for 1′ and one cycle at 72◦C for 20′. The specific PCR primer
sequences used were HHV6AdUT: Forward (F): 5′-GGATCC
ATGTACAGCGCAATTTCAG-3′, Reverse (R): 5′-AAGCTT
TTAAGCGTTATTGGAGGC-3′; HHV8dUT: F: 5′-CTTGGAT
CCATGAACAACCGCCGAGGC-3′, R: 5′-CCGGTTGAATTCTT
AC TAAAACCCAGA-3′; HSV2dUT: F: 5′-CTCGAGATGAGTCA
GTGGGGGCCCAGGGC-3′, R: 5′-GAATTCCTAGATGCCAGT
GGAGCCAAACC-3′; VZVdUT: F: 5′-CTCGAGATTGATCCC
ATCTT GGAAACGGC-3′, R: 5′-GAATTCTTAATGTTTTAG
TAGAAAATCGAC-3′; and HudUT: F: 5′-AAGCTTGGATCC
ATGCAGCTCCGCTTTGC-3′, R: 5′-TCCACTGGAAAGA
ATTAAGAATTCGT CGAC-3′. The PCR product was purified
using the QIAquick gel extraction kit (QIAGEN) and cloned
into the protein expression vector pTrcHis Topo (Invitrogen).
Twenty individual clones for each dUTPase construct type were
isolated following transformation of E. coli Top 10 competent
cells, DNA was then purified using the QIAPrep Spin Miniprep
kit (QIAGEN), screened by PCR for the presence of specific
dUTPase genes and the sequence verified by DNA sequencing
analysis. The pTrcHisdUT constructs, containing the specific
dUTPase gene of interest in the correct orientation and in frame,
were used to transform E. coli BL21(DE3)plyS competent cells for
purification of recombinant proteins as described below.
PURIFICATION OF RECOMBINANT HERPESVIRUSES’ dUTPase
PROTEINS
The recombinant herpesviruses’ dUTPase proteins as well as
the human dUTPase protein were purified using HisPur™ Spin
columns (3ml resin bed) as described by the manufacturer
(Pierce, Rockford, IL). Briefly, BL21(DE3)plyS containing a spe-
cific pTrcHisDUT construct was grown in LBmedium containing
chloramphenicol (25μg/ml) and ampicillin (100μg/ml) at 37◦C
for 2.5 h. IPTG (1mM final concentration) was added and the
culture was incubated an additional 2 h at 37◦C. Bacteria were
collected from 1 to 2 liters of medium by low speed centrifugation
and the bacterial pellet was resuspended in 50ml of extraction
buffer (50mM sodium phosphate, 300mM NaCl and 10mM
imidazole, pH 7.4). Bacteria were lysed by ultrasonication. The
resulting homogenate was centrifuged (15,000 × g, 30min at
4◦C), and the supernatant was applied to a HisPur™ spin col-
umn, which was equilibrated in extraction buffer. The column
was washed three times with two-resin bed volumes of extraction
buffer and the dUTPase proteins eluted by washing the column
four times with one resin-bed volume of 50mM sodium phos-
phate, 300mM NaCl and 150mM imidazole, pH 7.4. Fractions
were assayed for dUTPase activity as described previously (Glaser
et al., 2006) and for protein using the Coomassie Brilliant Blue
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dye-binding assay (Bio-Rad Laboratories) and bovine serum
albumin as the standard. A unit of dUTPase activity was defined
as the amount of enzyme required to convert 1 nmole of dUTP to
dUMP and pyrophosphate per min at 37◦C under the assay con-
ditions. Purity of all recombinant dUTPases (herpesviruses and
human encoded) was determined by SDS-PAGE as described pre-
viously (Glaser et al., 2006; Ariza and Williams, 2011). Proteins
were visualized using EZBlue™ protein gel stain, as described by
the manufacturer (Sigma Aldrich, St. Louis, MO). All recom-
binant herpesviruses and human dUTPase protein preparations
were tested for the presence of contaminants as described previ-
ously (Glaser et al., 2006; Ariza et al., 2009; Ariza and Williams,
2011; Ariza et al., 2013) and were free of detectable levels of LPS,
peptidoglycan (SLP-HS), DNA or RNA. The purified recombi-
nant herpesviruses-encoded and human dUTPase proteins used
in these studies were stored at −80◦C at stock concentrations of
0.2 and 0.5mg/ml.
CELL CULTURE
Human dendritic cells (hDC/LCs; myeloid, plasmacytoid and
Langerhan cells) were obtained from MatTek Corporation
(Ashland MD). These cells were generated from CD34+ pro-
genitor cells derived from human umbilical cord blood (HUCB)
cells and cultured using specially formulated medium, DC-100-
MM (MatTek), containing a cytokine cocktail designed to induce
differentiation of the CD34+ into DCs. These DCs express sur-
face markers CD1a, HLA-DR, co-stimulatory molecules, Birbeck
granules and surface markers characteristic of both plasmacytoid
and myeloid DC (Ayehunie et al., 2003).
Human embryonic kidney 293 (HEK293) cell lines stably
expressing either human TLR2 (TLR2-HEK293) or TLR2/TLR6
(TLR2/TLR6-HEK293) as well as control cells (HEK293
WT) were purchased from Invivogen (San Diego, CA). All
cell lines were maintained in DMEM supplemented with
L-glutamine (2mM), 4.5 g/l glucose, sodium pyruvate (1%),
10% heat-inactivated FBS, 50 U/ml penicillin, 50μg/ml strep-
tomycin, 100μg/ml Normocin™, plus 10μg/ml blasticidin
(TLR2-HEK293; TLR2/TLR6-HEK293).
Human peripheral blood mononuclear cells (PBMCs) from
healthy subjects were obtained from Astarte Biologics (Cat# 1001
Lot # 1704OC12).
LUCIFERASE REPORTER GENE ASSAYS
HEK293 cells (TLR2-HEK293, TLR2/TLR6-HEK293 and
HEK293 WT) (2.5 × 105) were seeded into 12-well plates and
24 h later transiently transfected using lipofectamine 2000 trans-
fection reagent (Invitrogen; Carlsbad, CA), as we have previously
described (Ariza et al., 2009, 2013; Ariza andWilliams, 2011). For
NF-κB reporter assays, cells were transfected with pNFκB-Luc
(0.5μg) and pRL-TK (8 ng) reporter vectors and co-transfected
with the expression plasmids pCMV-TLR1, pCMV-MyD88
dominant-negative (MyD88DN), pZero-hTLR2 dominant-
negative (TLR2DN) or empty vector (0.3μg), as described
in the figure legends. All luciferase experiments described in
Figures 2, 3 were performed simultaneously, repeated three
times and empty vector was used as a control/carrier to keep the
total amount of transfected-DNA constant. At 24–36 h following
transfection, cells were treated with various concentrations
(0–10μg/ml) of purified recombinant dUTPase proteins from
HSV-2, HHV-6A, HHV-8 and VZV or left untreated for 8 h.
Specific TLR ligands (zymosan: 10μg/ml; Pam3Csk4: 0.1μg/ml;
and FSL-1: 0.1μg/ml) were used as positive controls for TLR2,
TLR1, and TLR6 (Ariza et al., 2009). Following treatment, cell
lysates were prepared and reporter gene activities were measured
using the dual-luciferase reporter system (Promega, Madison,
WI), as we have described (Ariza et al., 2009; Ariza and Williams,
2011; Ariza et al., 2013). Data were normalized for transfection
efficiency by measuring Renilla luciferase activity and expressed
as the mean relative stimulation ± SD.
HUMAN TLR2 BLOCKING EXPERIMENTS
TLR2-expressing HEK293 cells were transiently transfected with
pNFκB-Luc and pRL-TK reporter vectors and co-transfected with
the expression plasmid pCMV-TLR1 or empty vector as described
above. At 24–36 h after transfection, cells were pretreated with
10μg/ml of either anti-human TLR2mAb (anti-TLR2mAb;
clone TL2.1) or IgG2a isotype control Ab for 1 h at 37◦C,
and subsequently treated with dUTPase proteins (10μg/ml)
encoded by HHV-6A, HHV-8 and VZV or left untreated for 8 h.
After treatment, cell lysates were prepared, and neutralization of
TLR2-mediated activation of NF-κB reporter gene activity was
determined using the dual-luciferase reporter assay as described
above (Ariza et al., 2009, 2013; Ariza and Williams, 2011).
Data were normalized for transfection efficiency by measuring
Renilla luciferase activity and expressed as the mean relative
stimulation ± SD.
CYTOKINE PROFILE INDUCED BY HERPESVIRUSES-ENCODED
dUTPases
hDCs and PBMCs were seeded at a density of 2.5 × 105 in 24-well
plates and cultured in AIM-V serum-free medium supplemented
with L-glutamine (2mM), streptomycin (50μg/ml) and gen-
tamycin (10μg/ml). The next day, cells were stimulated with the
herpesviruses-encoded dUTPases (0.1 or 10μg/ml), Pam3Csk4
(0.1μg/ml; as described previously, Ariza et al., 2013), or left
untreated for 24 h. Nuclear human dUTPase protein (10μg/ml)
was used as a control. Following treatment, cell culture super-
natants were collected and the levels of cytokines in treated and
control samples were measured by ELISA (MSD Multi-array and
Multi-spot human cytokine kit) as we have described previously
(Ariza et al., 2013). Concentrations are expressed as pg/ml and
represent the mean ± SD of an n of 4.
For blocking experiments, hDCs and PBMCs were seeded at
a density of 2.5 × 105 in 24-well plates and cultured in AIM-
V serum-free medium supplemented with L-glutamine (2mM),
streptomycin (50μg/ml) and gentamycin (10μg/ml). The next
day, cells were pretreated with (10μg/ml) anti-human TLR2
monoclonal antibody (anti-TLR2 MAb; clone TL2.1) or IgG2a
MAb isotype control for 1 h at 37◦C and subsequently exposed
to the herpesviruses-encoded dUTPases (10μg/ml), Pam3Csk4
(0.1μg/ml; as described previously, Ariza et al., 2013) or left
untreated for 24 h. Following treatment, cell culture supernatants
were collected and the levels of pro-inflammatory cytokines in
treated and control samples were measured by ELISA as we have
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described (Ariza et al., 2013). Concentrations are expressed as
pg/ml and represent the mean ± SD of an n of 4.
STATISTICAL ANALYSIS
Statistical analyses were performed using a paired two-sample
t-test for the means. For comparison of cytokine production
induced by each specific herpesvirus-encoded dUTPase treatment
relative to the untreated control, the Student’s t test was used
and p values reported when significant (p < 0.05). A two-sample
t-test was also used to compare cytokine levels among groups in
the presence or absence of blocking antibody. Values represent the
mean ± SD of at least three independent experiments.
RESULTS
PURIFICATION OF RECOMBINANT HIS-TAGGED
HERPESVIRUSES-ENCODED dUTPases
The recombinant his-tagged herpesviruses-encoded dUTPase
proteins were routinely purified 520–830-fold using HisPur™
affinity chromatography. Molecular weights of the recombinant
his-tagged dUTPase proteins based upon SDS-PAGE were 42,
48, 40, and 50 kDa for HSV-2, HHV-6A, HHV-8, and VZV,
respectively, which coincide with the molecular weights pre-
dicted for these recombinant proteins. Based upon the sensi-
tivity (5 ng) of the EZBlue™ stain, the purified recombinant
herpesviruses-encoded dUTPase proteins were estimated to be
greater than 99% homogeneous (data not shown). To ensure
the high purity of the recombinant dUTPase proteins, all her-
pesviruses his-tagged recombinant dUTPase preparations were
tested as described previously (Glaser et al., 2006; Ariza et al.,
2009; Ariza and Williams, 2011) and shown to be peptidogly-
can (SLP-HS), DNA/ RNA and endotoxin free (<0.08 IU/ml).
With the exception of the HHV-6A recombinant dUTPase pro-
tein, which had no detectable enzymatic activity under our assay
conditions, all the remaining recombinant his-tagged dUTPase
proteins (HSV-2: 10.4 ± 0.53; HHV-8: 5.8 ± 0.23 and VZV:
6.3 ± 0.42 units/mg protein) possessed enzymatic activity specific
for dUTP. The protein sequences for the cloned dUTPase genes
are shown in Figure 1.
THE HERPESVIRUSES-ENCODED dUTPases INDUCE THE
TRANSCRIPTIONAL ACTIVATION OF NF-κB VIA TLR2/TLR1
To determine whether human herpesviruses-encoded dUTPase
proteins could activate NF-κB through TLR2 in a similar man-
ner as the EBV-encoded dUTPase, HEK293 cells were transiently
transfected with vectors encoding the NF-κB luciferase reporter
gene, transfection control pRL-TK and co-transfected with either
the expression plasmid pCMV-TLR1 (TLR2-HEK293 cells), or
empty pCMV vector (HEK293 WT cells). Empty pCMV vector
was used as a carrier to keep the total amount of transfected-
DNA constant. TLR2-HEK293 cells transfected with pCMV-
TLR1 are referred to from here on as TLR2/TLR1-HEK293. After
24–36 h, cells were stimulated with the human herpesviruses-
encoded dUTPases (0–10μg/ml), or no stimulation for 8 h.
Treatment of TLR2/TLR1-HEK293 cells with various concen-
trations of the herpesviruses-encoded dUTPases resulted in the
activation of NF-κB in a dose-dependent manner, ranging from
2 to 101-fold induction (Figures 2A–D) relative to the untreated
control. However, treatment of control HEK293 cells with the
herpesviruses-encoded dUTPases did not result in the activa-
tion of the NF-κB promoter (Figures 2A–D). Interestingly, the
highest level of NF-κB activation was induced by HHV-8 fol-
lowed by HHV-6A and VZV encoded dUTPases with HSV-2-
encoded dUTPase (Figure 2A) inducing the lowest level of NF-κB
activation.
Simultaneously, the TLR2-HEK293 and TLR2/TLR6-HEK293
cell lines were employed to determine whether the activa-
tion of NF-κB induced by the herpesviruses-encoded dUTPases
involved the formation of TLR2 homodimers or TLR2/TLR6
heterodimers. Cells were transiently transfected with vectors
encoding the NF-κB luciferase reporter gene, transfection con-
trol pRL-TK and co-transfected with empty vector control,
followed by treatment with the herpesviruses-encoded dUT-
Pases (10μg/ml), zymosan (a TLR2 ligand), FSL-1 (a TLR6
ligand) or no treatment for 8 h, as described in Materials
and Methods. As shown in Figure 3A, treatment of TLR2-
HEK293 cells with the herpesviruses-encoded dUTPases from
HSV-2, HHV-6A, HHV-8, and VZV resulted in either no
activation of the NF-κB promoter (HSV-2: 1.1) or a much
weaker activation (HHV-6A: 7.8; HHV-8: 10; VZV: 8-fold
induction) than that observed in TLR2/TLR1-HEK293 express-
ing cells treated with the same concentration (HSV-2: 4.5;
HHV-6A: 74; HHV-8: 101; VZV: 78-fold induction). Similarly,
treatment of TLR2/TLR6-HEK293 cells (Figure 3B) with these
herpesviruses-encoded dUTPases (10μg/ml) induced a higher
activation (HHV-6A: 17; HHV-8: 34; VZV: 18-fold induction) of
NF-κB than in HEK293 cells just expressing TLR2, but weaker
than what was observed in TLR2/TLR1-HEK293 expressing cells
(Figures 2B–D). All together, these data demonstrate that the
herpesviruses-encoded dUTPases serve as pathogen-associated
molecular pattern (PAMP) proteins and are most efficiently rec-
ognized by TLR2/TLR1 heterodimers.
To further confirm that the herspesviruses-encoded
dUTPases serve as PAMP proteins recognized by TLR2/TLR1,
TLR2-HEK293 cells were transfected with pCMV-TLR1 and
co-transfected with either a dominant-negative expression plas-
mid of TLR2 (pZero-hTLR2; [TLR2DN] lacks the TIR domain)
or empty vector, followed by treatments with the dUTPases
(10μg/ml) encoded by HHV-6A, HHV-8 and VZV, Pam3Csk4
(0.1μg/ml) or left untreated for 8 h. Human dUTPase protein
(10μg/ml), was used as a control. As demonstrated in Figure 4A,
all herspesviruses-encoded dUTPase recombinant proteins,
except the human dUTPase, induced NF-κB activity. However,
overexpression of TLR2DN blocked the activation of NF-κB
induced by all herpesviruses-encoded dUTPases (HHV-6A,
HHV-8, VZV) and Pam3Csk4.
In order to demonstrate conclusively that the herpesviruses-
encoded dUTPases are recognized by TLR2/TLR1, we next
performed blocking experiments using anti-TLR2 or isotype
control Abs. TLR2-expressing HEK293 cells were transiently
transfected with the pNF-κB luciferase reporter and pRL-TK
plasmids and co-transfected with pCMV-TLR1 expression
vector or empty plasmid. After 24–36 h, cells were incubated
with anti-TLR2 or IgG2a isotype control Abs (10μg/ml)
for 1 h prior to treatment with the dUTPases encoded by
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FIGURE 1 | Herpesviruses-encoded dUTPase proteins. CLUSTAL Omega (1.2.0) multiple sequence alignment of herpesviruses-encoded dUTPase
recombinant proteins used in this study.
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FIGURE 2 | Herpesviruses-encoded dUTPases induce differential NF-κB
activation through TLR2/TLR1 heterodimers. Dose-response activation of
NF-κB by purified recombinant dUTPase proteins from (A) herpes simplex
virus type 2 (HSV-2), (B) human herpesvirus-6A (HHV-6A), (C) human
herpesvirus-8 (HHV-8), (D) varicella-zoster virus (VZV), in TLR2-HEK293 and
HEK293 wild-type control cell lines, as determined by luciferase reporter
assay. HEK293 cells were transiently transfected with NF-κB luciferase and
pRL-TK reporter plasmids and co-transfected with pCMV-TLR1 (TLR2HEK293
cells), or empty vector (HEK293 WT cells), as described in Materials and
Methods and by our group (Ariza et al., 2009, 2013; Ariza and Williams, 2011).
Empty vector was used as a carrier to keep the total amount of
transfected-DNA constant. After 24–36 h, cells were treated with various
concentrations of the herpesviruses-encoded dUTPase proteins (0–10μg/ml),
or left untreated for 8 h and luciferase reporter gene activity was measured.
Data were normalized for transfection efficiency by measuring Renilla
luciferase activity and expressed as the mean fold induction ± SD relative to
untreated control levels. Values represent the average of three independent
experiments.
HHV-6A, HHV-8 and VZV or Pam3Csk4 for an addi-
tional 8 h. As shown in Figure 4B, while pre-treatment
with isotype control Ab had no effect on the ability of
the herpesviruses-encoded dUTPases to stimulate NF-κB
reporter activity, the anti-TLR2 Ab effectively blocked/inhibited
NF-κB activation by these viral dUTPases. These data
demonstrate that the activation of NF-κB induced by the
herpesviruses-encoded dUTPases is dependent on TLR2/TLR1
heterodimers.
To determine whether the adapter molecule MyD88 was
involved in herpesviruses-encoded dUTPases signaling through
TLR2/TLR1 heterodimers, TLR2/TLR1-HEK293 expressing cells
were co-transfected with either MyD88DN, a plasmid expressing
a dominant-negative form of MyD88, or empty vector, followed
by treatment with the viral (HHV-6A, HHV-8, VZV) dUTPases
(10μg/ml), Pam3Csk4 (0.1μg/ml), or left untreated for 8 h. As
expected, overexpression of MyD88DN prevented the activation
of NF-κB by the herpesviruses-encoded dUTPases and Pam3Csk4
treatments (Figure 4C).
THE HERPESVIRUSES-ENCODED dUTPases INDUCE THE SECRETION OF
CYTOKINES IN HUMAN DCs (hDCs) AND PBMCs
We have previously demonstrated that the EBV-encoded dUT-
Pase induced the production of pro-inflammatory cytokines
in PBMCs, human monocyte derived macrophages and hDCs
(Glaser et al., 2006;Waldman et al., 2008; Ariza et al., 2009, 2013).
To determine whether the dUTPases encoded by other human
herpesviruses induced the production of pro-inflammatory
cytokines, ELISA studies were performed in hDCs and PBMCs
treated with herpesviruses-encoded dUTPases, control human
recombinant dUTPase or left untreated for 24 h, as described
in Materials and Methods. Pam3Csk4 (0.1μg/ml) was used
as a control, as we have previously described (Ariza et al.,
2013). As shown in Tables 1, 3, 5, treatment of primary hDCs
with dUTPase recombinant proteins from HHV-6A, HHV-8 and
VZV resulted in a statistically significant (p < 0.05) increase
in the production of cytokines IL-10, IL12p70, IL-1β, IL-6,
IL-8, and TNF-α, even at dUTPase concentrations as low as
0.1μg/ml. Conversely, only cytokines IL-6 and IL-8 (Table 7)
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FIGURE 3 | Activation of NF-κB by herpesviruses-encoded dUTPases is
weaker in TLR2/TLR6-HEK293 than in TLR2/TLR1-HEK293 expressing
cells. Herpesviruses-encoded dUTPases mediated activation of NF-κB in
(A) TLR2-HEK293 and (B) TLR2/TLR6-HEK293 cell lines. Cells were
transiently transfected with NF-κB luciferase and pRL-TK reporter plasmids
and co-transfected with empty vector, as described in Materials and
Methods. Empty vector was used as a carrier to keep the total amount of
transfected-DNA constant. After 24–36 h, cells were treated with various
herpesviruses-encoded dUTPases (10μg/ml) or left untreated for 8 h, and
NF-κB luciferase levels were measured. Zymosan (10μg/ml) and FSL-1
(0.1μg/ml) were used as positive controls for TLR2 and TLR6 activation,
respectively. Data were normalized for transfection efficiency by measuring
Renilla luciferase activity and expressed as the mean fold induction ± SD
relative to control levels. Values represent the average of three independent
experiments.
were significantly induced by the HSV-2-encoded dUTPase at
the lowest concentration (0.1μg/ml) tested (p < 0.05). Similarly,
while all the herpesviruses-encoded dUTPases induced a sta-
tistically significant (p < 0.05) increase in the production of
cytokines in PBMCs at the highest concentration (10μg/ml)
(Tables 2, 4, 6, 8), only the dUTPases encoded by HHV-8 and
VZVwere capable of inducing a statistically significant (p < 0.05)
increase in the production of cytokines (Table 4: IFN-γ, IL-1β
and TNF-α; and Table 6: IL-10, IL-1β, and IL-8), at the low-
est concentration (0.1μg/ml). Interestingly, the nuclear human
dUTPase, which was used as a control protein, did not induce a
FIGURE 4 | Herpesviruses-encoded dUTPases signal through
TLR2/TLR1 and MyD88. TLR2- HEK293 cells were transiently transfected
with NF-κB luciferase and pRL-TK reporter plasmids and co-transfected
with pCMV-TLR1 and either TLR2DN, a vector that expresses a
dominant-negative form of TLR2, or empty vector (0.3μg) (A). After
24–36 h, cells were treated with the dUTPases (10μg/ml) encoded by
HHV-6A, HHV-8 and VZV or left untreated for 8 h, and luciferase reporter
gene activity was measured. Pam3Csk4 (0.1μg/ml) was used as a positive
control for TLR2/TLR1 activation and nuclear human dUTPase was used as
a control protein. (B) Anti-TLR2 blocking Ab inhibits NF-κB activation by the
herpesviruses-encoded dUTPases. TLR2-HEK293 cells were transiently
(Continued)
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FIGURE 4 | Continued
transfected with NF-κB luciferase and pRL-TK reporter plasmids and
co-transfected with pCMV-TLR1. After 24–36 h, cells were pre-incubated
with isotype control (IgG2a) or anti-TLR2 mAbs (10μg/ml) for 1 h followed
by treatment with either herpesviruses-encoded dUTPases (10μg/ml),
Pam3Csk4 for 8 h or left untreated and luciferase reporter gene activity was
measured. (C) TLR2-HEK293 cells were transiently transfected with NF-κB
luciferase and pRL-TK reporter plasmids and co-transfected with
pCMV-TLR1 and either MyD88DN, a vector that expresses a
dominant-negative form of MyD88, or empty vector. After 24–36 h, cells
were treated with either herpesviruses-encoded dUTPases (10μg/ml),
Pam3Csk4 or left untreated for 8 h and luciferase reporter gene activity was
measured. Data are expressed as the mean fold induction ± SD relative to
control levels. Values represent the average of three independent
experiments.
statistically significant secretion of cytokines even at the highest
concentration (10μg/ml) tested following stimulation of primary
DCs (Table 9) or PBMCs (data not shown), consistent with our
previously published work (Ariza et al., 2013). These data demon-
strate that there are differences in the levels of cytokines induced
in response to the various herpesviruses-encoded dUTPases used
in this study with HSV-2 exhibiting the lowest cytokine response.
HUMAN HERPESVIRUSES-ENCODED dUTPases INDUCE CYTOKINES IN
HUMAN PRIMARY DCs AND PBMCs IN A TLR2-DEPENDENT MANNER
To determine whether herpesviruses-encoded dUTPases medi-
ated induction of cytokines was TLR2 dependent, blocking
experiments were performed. hDCs and PBMCs were incu-
bated with anti-TLR2 or isotype control (IgG2a) antibodies
(10μg/ml) for 1 h, followed by treatment with specific viral dUT-
Pases encoded by HHV-6A, HHV-8 and VZV or left untreated
for 24 h, as we have described (Ariza et al., 2009, 2013).
Pam3Csk4 (0.1μg/ml) was used as a control, as we have pre-
viously described (Ariza et al., 2013). After 24 h, culture super-
natants from control and treated samples were collected and
analyzed for cytokine levels by ELISA. Treatment of hDCs and
PBMCS with anti-TLR2 antibody resulted in a statistically sig-
nificant (p < 0.05) decrease in the production of cytokines from
hDCs and PBMCs treated with dUTPases encoded by HHV-6A
(Tables 1, 2), HHV-8 (Tables 3, 4), and VZV (Tables 5, 6), respec-
tively. However, pre-incubation of cells with the isotype control
antibody did not inhibit the secretion of cytokines induced by
herpesviruses-encoded dUTPases in PBMCs or hDCs.
DISCUSSION
The human herpesviruses are a diverse group of organisms
exhibiting different cellular tropisms and they are associated
with several diseases that have significantly different clinical pre-
sentations and outcomes. However, these viruses share several
common features such as transmission, which involves contact
with host mucosa where they interact with resident cells, includ-
ing macrophages and DCs, and establish persistent infections.
DCs and macrophages are professional antigen presenting cells
(APC) that have key roles in regulating immune responses to host
pathogens. Considering the roles that these cells have in initiat-
ing an immune response against pathogens and the ability of the
human herpesviruses to establish persistent infections, it is likely
that these viruses have developed mechanism(s) to modulate the
functions of DCs and macrophages. While these cell types are
not considered to be the primary targets for infection by human
herpesviruses, there is accumulating evidence demonstrating that
these viruses infect monocytes, macrophages and DCs result-
ing in non-productive, productive or latent infections (Kondo
et al., 1991; Blasig et al., 1997; Hahn et al., 1998; Savard et al.,
2000; Abendroth et al., 2001; Mikloska et al., 2001; Zhang et al.,
2001; Kakimoto et al., 2002; Li et al., 2002; Morrow et al., 2003;
Senechal et al., 2004; Smith et al., 2005; Rappocciolo et al., 2006;
Walling et al., 2007; Huch et al., 2010; Goldwich et al., 2011;
Wang et al., 2012), in addition to altering their functions (Kruse
et al., 2000; Niiya et al., 2004; West et al., 2011; Gregory et al.,
2012; Gustafsson et al., 2013; Stefanidou et al., 2013). With the
exception of the γ34.5 protein, which has been reported to inter-
fere with DC maturation during HSV-1 infections (Jin et al.,
2009; West et al., 2011; Gobeil and Leib, 2012), virus-encoded
macromolecules that modulate DC/macrophage maturation and
function remain unknown. Another common characteristic of
these viruses is their ability to induce the increased secretion of
various pro-inflammatory cytokines/chemokines that are either
host-derived or virus-encoded, which contribute to the patho-
physiology of the virus-associated disease (Compton et al., 2003;
Kurt-Jones et al., 2004; Aravalli et al., 2005; Wang et al., 2005;
Glaser et al., 2006; Waldman et al., 2008; Ariza et al., 2009, 2013;
Gregory et al., 2012). Several studies have demonstrated that
the stimulation of TLR2 on monocytes, macrophages or DCs by
intact virions or in some cases by herpesvirus-encoded glyco-
proteins results in the increased secretion of pro-inflammatory
cytokines (Compton et al., 2003; Kurt-Jones et al., 2004; Aravalli
et al., 2005; Wang et al., 2005; Boehme et al., 2006; Sato et al.,
2006; Gaudreault et al., 2007; Paludan et al., 2011; Cal et al., 2012;
Leoni et al., 2012).
Recent studies by our group as well as others have shown
that the dUTPases encoded by the gamma herpesviruses possess
novel functions independent of their enzymatic activity (Glaser
et al., 2006; Waldman et al., 2008; Ariza et al., 2009, 2013; Leang
et al., 2011; Madrid and Ganem, 2012). Our studies with EBV
were the first to demonstrate that the EBV-encoded dUTPase
possesses novel functions in innate and adaptive immunity due
in part to the activation of TLR2, NF-κB and the subsequent
modulation of downstream genes involved in cytokine-receptor
signaling pathways, type I/II interferons (IFN) production and
effector T-cell function (Glaser et al., 2006; Waldman et al.,
2008; Ariza et al., 2009, 2013). The primary cellular targets of
the EBV-encoded dUTPase appear to be monocytes and den-
dritic cells (Glaser et al., 2006; Waldman et al., 2008; Ariza et al.,
2009, 2013). Studies with murine γ-herpesvirus-68 (γ-68) have
shown that the γ-68-encoded dUTPase (ORF54) possesses anti-
interferon properties and is necessary for efficient replication of
the virus in the lungs of infected mice (Leang et al., 2011). Madrid
and Ganem (2012) reported that the HHV-8- encoded dUTPase,
but not the EBV-encoded dUTPase, down-regulated the expres-
sion of NKp44L, a “cytotoxicity” receptor on natural killer (NK)
cells, suggesting that the HHV-8-encoded dUTPase was involved
in immune evasion. However, studies on the potential role of
the herpesviruses-encoded dUTPases in pathogenesis have been
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Table 1 | Cytokine profile induced by HHV6A-encoded dUTPase in hDCs.
Treatmentsa IL-10 IL12p70 IL-1β IL-6 IL-8 TNFα
Untreated 0.64±0.61 1.83±0.84 1.75±0.21 1.79±1.05 304.22±1.31 13.58± 1
HHV6AdUTPase (0.1μg/ml) 10.52±0.8** 6.26±0.92* 3.91±0.37** 44.08±2.96** 1523.02±38.47** 36.61± 5.51**
HHV6A-dUTPase (10μg/ml) 61.63±5.02** 32.40±3.46* 6.33±0.75** 217.48±27.35** 9130.50±934.73** 177.89± 26.66**
HHV6A-dUTPase + TLR2 Ab 15.01±0.61** 20.55±6.91 2.44±0.12** 96.13±7.19** 4370.80±43.96** 70.14± 8.32*
HHV6A-dUTPase + Isotype Ctl Ab 58.03±3.45 27.33±3.15 6.09±0.99 207.15±9.12 8130.30±855.04 156.68± 21.19
ahDCs were treated with HHV6A-encoded dUTPase (0.1 and 10µg/ml) or left untreated, as described in Materials and Methods. For blocking experiments, hDCs
were pre-incubated with anti-TLR2 or isotype control Abs (10µg/ml) for 1h and subsequently treated with HHV6A-encoded dUTPase (10µg/ml), as described in
Materials and Methods. After 24 h, culture supernatants were collected for cytokine analysis by ELISA as we have described (Ariza et al., 2009, 2013). Cytokine
levels are expressed as pg/ml. Data represent the means ± SD of an n of 4. *p < 0.05, **p < 0.01 (Groups compared: dUTPase treated vs. untreated or TLR2 Ab
treated vs. isotype control Ab treated samples).
Table 2 | Cytokine profile induced by HHV6A-encoded dUTPase in PBMCs.
Treatmentsa IFN-γ IL-10 IL12p70 IL-1β IL-6 IL-8 TNFα
Untreated 3.75± 2.84 0.82±0.67 26.46± 5.84 0.56± 0.30 29.95± 10.93 3910.50 ± 133 58.49 ± 23.45
HHV6A-dUTPase (0.1μg/ml) 4.01± 1.04 0.75±0.19 21.79± 1.92 0.50± 0.14 30.79± 3.47 4021 ± 138 61.47 ± 7.51
HHV6A-dUTPase (10μg/ml) 322.24± 14.38** 210.31±2.52** 292.65± 28.49** 38.17± 3.56** 3571.08± 102.51** 44,297 ± 523** 11,822 ± 125**
HHV6A-dUTPase + TLR2 Ab 109.73± 28.04** 71.52±6.29** 54.13± 3.86** 18.20± 3.07** 1903.74± 227.85** 4293 ± 47** 7051.25 ± 495.74**
HHV6A-dUTPase + Isotype Ctl Ab 342.06± 39.50 219.78±9.52 334.29± 10.11 33.17± 0.42 3701.36± 20.04 45,154 ± 1.41 12,214.48 ± 83
aPBMCs were treated with HHV6A-encoded dUTPase (0.1 and 10µg/ml) or left untreated, as described in Materials and Methods. For blocking experiments, PBMCs
were pre-incubated with anti-TLR2 or isotype control Abs (10µg/ml) for 1 h and subsequently treated with HHV6A-encoded dUTPase (10µg/ml) or left untreated, as
described in Materials and Methods. After 24 h, culture supernatants were collected for cytokine analysis by ELISA as we have described (Ariza et al., 2009, 2013).
Cytokine levels are expressed as pg/ml. Data represent the means ± SD of an n of 4. **p < 0.01 (Groups compared: dUTPase treated vs. untreated or TLR2 Ab
treated vs. isotype control Ab treated samples).
Table 3 | Cytokine profile induced by HHV8-encoded dUTPase in hDCs.
Treatmentsa IL-10 IL12p70 IL-1β IL-6 IL-8 TNFα
Untreated 0.64±0.61 1.83±0.84 1.75±0.21 1.79±1.05 304.22±1.31 13.58± 1
HHV8-dUTPase (0.1μg/ml) 4.70±0.74** 5.65±2.69* 2.65±0.05** 21.86±2.47** 1091.73±102.81** 27.26± 4.70**
HHV8-dUTPase (10μg/ml) 47.83±2** 33±1.85** 5.46±0.48** 157.39±11.17** 7716.23±144.95** 155.31± 12.78**
HHV8-dUTPase + TLR2 Ab 8.49±0.6** 20.57±1.60** 1.74±0.10** 73.60±6.07** 2229.22±112.71** 60.81± 5.72**
HHV8-dUTPase + Isotype Ctl Ab 45.55±2.11 31.99±5.84 4.81±0.70 160.39±15.18 7025.33±76.36 146.30± 7.87
ahDCs were treated with HHV8-encoded dUTPase (0.1 and 10µg/ml) or left untreated, as described in Materials and Methods. For blocking experiments, hDCs
were pre-incubated with anti-TLR2 or isotype control Abs (10µg/ml) for 1 h and subsequently treated with HHV8-encoded dUTPase (10µg/ml) or left untreated, as
described in Materials and Methods. After 24 h, culture supernatants were collected for cytokine analysis by ELISA as we have described (Ariza et al., 2009, 2013).
Cytokine levels are expressed as pg/ml. Data represent the means ± SD of an n of 4. *p < 0.05, **p < 0.01 (Groups compared: dUTPase treated vs. untreated or
TLR2 Ab treated vs. isotype control Ab treated samples).
limited. Furthermore, there have not been any studies to address
the role of dUTPases-encoded by the alpha or beta herpesviruses
as possible immune modulators. Several studies have demon-
strated the expression of the EBV- andHHV-8-encoded dUTPases
in human malignancies associated with these viruses (Kremmer
et al., 1999; Fleischmann et al., 2002), and anti-dUTPase anti-
bodies have been detected in the serum of patients with several
EBV-associated diseases (Fleischmann et al., 2002). Most impor-
tantly, we have demonstrated that the presence of antibodies to
the EBV-encoded dUTPase may be useful in diagnosing a subset
of patients with chronic fatigue syndrome (Lerner et al., 2012) as
well as some patients with acute myocardial infarction (Binkley
et al., 2013), which further support a role for the EBV-encoded
dUTPase in these processes.
Since herpesviruses-encoded dUTPases lack consensus secre-
tory sequences, it has been suggested that the release of these
proteins could only occur as a result of cell lysis following lytic
replication of the virus. However, there is accumulating evi-
dence, especially in the case of the gamma herpesviruses (Laichalk
and Thorley-Lawson, 2005; Al Tabaa et al., 2009, 2011; Myoung
and Ganem, 2011; Scholz et al., 2013; Strong et al., 2013), sup-
porting the premise that “in vivo abortive-lytic replication” is
the predominant type of replication occurring in infected cells,
which results in the production of immediate early and early
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Table 4 | Cytokine profile induced by HHV8-encoded dUTPase in PBMCs.
Treatmentsa IFN-γ IL-10 IL12p70 IL-1β IL-6 IL-8 TNFα
Untreated 3.75± 2.84 0.82± 0.67 26.46±5.84 0.56±0.30 29.95±10.93 3910.50±133 58.49± 23.45
HHV8-dUTPase (0.1μg/ml) 7.07± 1.55* 1.46± 0.40 28.72±2.23 1.14±0.45* 37.26±10.06 4080±45 82.37± 5.20
HHV8-dUTPase (10μg/ml) 316.49± 3.89** 205.15± 17.35** 316.59±10.37** 35.35±4.04** 3433.72±116.53** 44,780±548** 11,935± 285**
HHV8-dUTPase + TLR2 Ab 123.53± 24.35** 75.58± 2.33** 51.02±2.09** 14.87±2.19** 1771.32±115.78** 4207±17** 6593.07± 300.90**
HHV8-dUTPase + Isotype Ctl Ab 304.41± 18.35 198.23± 0.82 314.21±8.52 38.26±5.64 3278.12±120.79 43,738.17±355.27 12,354.62± 306.76
aPBMCs were treated with HHV8-encoded dUTPase (0.1 and 10µg/ml) or left untreated, as described in Materials and Methods. For blocking experiments, PBMCs
were pre-incubated with anti-TLR2 or isotype control Abs (10µg/ml) for 1 h and subsequently treated with HHV8-encoded dUTPase (10µg/ml) or left untreated, as
described in Materials and Methods. After 24 h, culture supernatants were collected for cytokine analysis by ELISA as we have described (Ariza et al., 2009, 2013).
Cytokine levels are expressed as pg/ml. Data represent the means ± SD of an n of 4. *p < 0.05, **p < 0.01 (Groups compared: dUTPase treated vs. untreated or
TLR2 Ab treated vs. isotype control Ab treated samples).
Table 5 | Cytokine profile induced by VZV-encoded dUTPase in hDCs.
Treatmentsa IL-10 IL12p70 IL-1β IL-6 IL-8 TNFα
Untreated 0.64±0.61 1.83±0.84 1.75±0.21 1.79±1.05 304.22±1.31 13.58± 1
VZV-dUTPase (0.1μg/ml) 13.23±0.24* 24.31±2.40** 4.91±1.59* 94.31±45.08* 2231.42±45.43** 47.69± 16*
VZV-dUTPase (10μg/ml) 76.34±16.11** 58.68±22.12** 8.28±1.73** 192.88±47.91** 4665.63±231.7** 112.06± 29.92**
VZV-dUTPase + TLR2 Ab 8.84±0.81** 23.76±1.70 2.07±0.14** 75.34±9.82** 4242.27±59.83** 68.74± 23.13*
VZV-dUTPase + Isotype Ctl Ab 78.41±0.89 56.30±7.66 7.21±0.37 172.12±12.73 4461.11±435.95 104.88± 16.29
ahDCs were treated with VZV-encoded dUTPase (0.1 and 10µg/ml) or left untreated, as described in Materials and Methods. For blocking experiments, hDCs were
pre-incubated with anti-TLR2 or isotype control Abs (10µg/ml) for 1 h and subsequently treated with VZV-encoded dUTPase (10µg/ml) or left untreated, as described
in Materials and Methods. After 24 h, culture supernatants were collected for cytokine analysis by ELISA as we have described (Ariza et al., 2009, 2013). Cytokine
levels are expressed as pg/ml. Data represent the means ± SD of an n of 4. *p < 0.05, **p < 0.01 (Groups compared: dUTPase treated vs. untreated or TLR2 Ab
treated vs. isotype control Ab treated samples).
Table 6 | Cytokine profile induced by VZV-encoded dUTPase in PBMCs.
Treatmentsa IFN-γ IL-10 IL12p70 IL-1β IL-6 IL-8 TNFα
Untreated 3.75± 2.84 0.82± 0.67 26.46± 5.84 0.56±0.30 29.95±10.93 3910.50± 133 58.49±23.45
VZV-dUTPase (0.1μg/ml) 8.28± 5.14 1.33± 0.41* 22.11± 1.96 0.92±0.17* 32.55±2.41 4120± 135* 62.62±8.04
VZV-dUTPase (10μg/ml) 265.55± 10.27** 176.14± 5.90** 360.62± 34.79** 31.60±2.21** 2621.20±119.19** 46,094± 407** 12,073.55±386.68**
VZV-dUTPase + TLR2 Ab 125.87± 39.45** 68.85± 13.23** 53.87± 2.50** 14.51±1.66** 1525.65±181.75** 4219± 55** 5835.86±154.34**
VZV-dUTPase + Isotype Ctl Ab 205.73± 23.70 189.61± 3.21 299.48± 20.02 33.49±1.76 2851.90±59.57 44,325± 503 11,632.16±173.55
aPBMCs were treated with VZV-encoded dUTPase (0.1 and 10µg/ml) or left untreated, as described in Materials and Methods. For blocking experiments, PBMCs
were pre-incubated with anti-TLR2 or isotype control Abs (10µg/ml) for 1 h and subsequently treated with VZV-encoded dUTPase (10µg/ml) or left untreated, as
described in Materials and Methods. After 24 h, culture supernatants were collected for cytokine analysis by ELISA as we have described (Ariza et al., 2009, 2013).
Cytokine levels are expressed as pg/ml. Data represent the means ± SD of an n of 4.*p < 0.05, **p < 0.01 (Groups compared: dUTPase treated vs. untreated or
TLR2 Ab treated vs. isotype control Ab treated samples).
proteins, but limited production of new virions. In addition,
it has been demonstrated that abortive replication of human
immunodeficiency virus (HIV-1) induces pyroptosis (Doitsh
et al., 2014; Monroe et al., 2014). Unlike apoptosis, cell death by
pyroptosis results in membrane rupture and release of cytoso-
lic components and macromolecules, which may activate innate
immune signaling pathways leading to the secretion of inflam-
matory cytokines (Sangiuliano et al., 2014; Upton and Chan,
2014). Since IL-1β is a key driver of pyroptosis and this cytokine
is induced by the herpesviruses-encoded dUTPases studied, it
is possible that pyroptosis may represent a potential mecha-
nism by which these dUTPases can be released from infected
cells.
An alternative mechanism to explain the release of
herpesviruses-encoded dUTPases, which does not require
cell lysis, is through microvesicles/exosomes. There is consid-
erable evidence demonstrating that several herpesviruses, the
gamma herpesviruses in particular, modify cellular exosomal
proteins (Meckes et al., 2013). Furthermore, viral-encoded
macromolecules are also secreted using this pathway (Flanagan
et al., 2003; Keryer-Bibens et al., 2006; Meckes et al., 2010;
Pegtel et al., 2010). In line with this premise, the human nuclear
isoform of the dUTPase has been shown to be secreted in
B-cell derived exosomes (Buschow et al., 2010). Furthermore,
we recently demonstrated that the EBV-encoded dUTPase is
secreted in exosomes during abortive-lytic replication and
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Table 7 | Cytokine profile induced by HSV-2-encoded dUTPase in hDCs.
Treatmentsa IL-10 IL12p70 IL-1β IL-6 IL-8 TNFα
Untreated 0.64±0.61 1.83±0.84 1.75±0.21 1.79±1.05 304.22±1.31 13.58±1
HSV-2-dUTPase (0.1μg/ml) 0.57±0.19 2.13±1.14 2.21±0.17 3.39±0.93* 429.36±15.94** 14.90±2.88
HSV-2-dUTPase (10μg/ml) 18.52±0.34** 14.68±0.87** 5.18±0.62** 71.42±4.21** 3438.26±155.56** 56±3.12**
ahDCs were treated with HSV-2-encoded dUTPase (0.1; 10µg/ml) or left untreated, as described in Materials and Methods. After 24 h, culture supernatants were
collected for cytokine analysis by ELISA as we have described (Ariza et al., 2009, 2013). Cytokine levels are expressed as pg/ml. Data represent the means ± SD of
an n of 4. *p < 0.05, **p < 0.01 (Groups compared: dUTPase treated vs. untreated control).
Table 8 | Cytokine profile induced by HSV-2-encoded dUTPase in PBMCs.
Treatmentsa IFN-γ IL-10 IL12p70 IL-1β IL-6 IL-8 TNFα
Untreated 3.75±2.84 0.82±0.67 26.46±5.84 0.56±0.30 29.95±10.93 3910.50±133 58.49±23.45
HSV-2-dUTPase (0.1μg/ml) 3.89±2.24 0.80±0.44 20.29±1.53 0.54±0.22 21.31±1.54 3906±163 47.92±11.63
HSV-2-dUTPase (10μg/ml) 141.64±29.58** 81.06±16.33* 78.11±40.70 19.52±2.84** 1604.69±153* 4398±36 4530.05±842**
aPBMCs were treated with HSV-2-encoded dUTPase (0.1 and 10µg/ml) or left untreated, as described in Materials and Methods. After 24 h, culture supernatants
were collected for cytokine analysis by ELISA as we have described (Ariza et al., 2009, 2013). Cytokine levels are expressed as pg/ml. Data represent the means ±
SD of an n of 4. *p < 0.05, **p < 0.01 (Groups compared: dUTPase treated vs. untreated control).
Table 9 | Cytokine profile induced by nuclear human-encoded dUTPase in hDCs.
Treatmentsa IL-10 IL12p70 IL-1β IL-6 IL-8 TNFα
Untreated 0.47±0.35 1.5±0.47 1±0.15 9.4±1.4 482.7±22.50 7± 0.65
Human-dUTPase (10μg/ml) 2.6±0.2 5.1±2.6 3.6±0.56 96.43±53 760.02±38.47 18.2± 2.5
ahDCs were treated with nuclear human-encoded dUTPase (10µg/ml) or left untreated, as described in Materials and Methods. After 24 h, culture supernatants
were collected for cytokine analysis by ELISA as we have described (Ariza et al., 2009, 2013). Cytokine levels are expressed as pg/ml. Data represent the means ±
SD of an n of 4.
that these dUTPase-containing exosomes induced a TH1/TH17
cytokine response that was TLR2-dependent (Ariza et al., 2013).
Interestingly, the human adenovirus type 9 E4-ORF1, which
encodes for an ancestral dUTPase (Weiss et al., 1997), is also
targeted to membrane vesicles (Chung et al., 2007). While there
is exciting accumulating literature demonstrating exosomes as
a mechanism for the release of several dUTPases of viral and
human origin, it is not known whether the dUTPases encoded
by other human herpesviruses are released in exosomes during
lytic/abortive-lytic replication of these viruses.
The data presented in this study demonstrate that the dUT-
Pases encoded by various human herpesviruses differentially
activate NF-κB and induce the secretion of pro-inflammatory
cytokines in a TLR2-dependent mechanism. Interestingly, the
data also demonstrate that the herpesviruses-encoded dUTPases
exhibit different TLR2 partners/complex formation preferences,
which influence the levels of NF-κB activation induced by these
viral dUTPases, as shown in Figures 2, 3. We have previously
reported that the maximal activation of NF-κB by the EBV-
encoded dUTPase is independent of TLR1 and TLR6 and requires
TLR2 homodimerization (Ariza et al., 2009). Conversely, this
study demonstrates rather conclusively that activation of NF-κB
by the HHV-6A, HHV-8, and VZV-encoded dUTPases occurs
by engaging TLR2/TLR1 heterodimers. This finding was further
confirmed by data demonstrating that activation of NF-κB by
the herpesviruses-encoded dUTPases is inhibited by TLR2 or
MyD88 dominant-negative mutants and anti-hTLR2 but not iso-
type control Abs (Figure 4). Finally, while the dUTPases encoded
by HHV-8, HHV-6A, and VZV were very effective at stimulating
NF-κB activity in TLR2 expressing HEK293 cells co-transfected
with pCMV-TLR1, the HSV-2-encoded dUTPase was the least
effective at all the concentrations tested.
These differences most likely reflect differences in intrinsic
properties of each viral protein including binding affinities of the
dUTPases to TLR2 and the overall structure of the dUTPases.
Proteins are classified as dUTPases based primarily on their enzy-
matic activity and, in the case of homotrimeric and monomeric
dUTPases, the presence of five conserved domains, which are
essential for the catalytic site of the enzyme (Baldo and McClure,
1999; McGeehan et al., 2001; Davidson and Stow, 2005). There
is little homology between these viral dUTPases except in the
five conserved domains involved with enzymatic activity, which
are lacking in all members of the β-herpesvirus family (Baldo
and McClure, 1999; McGeehan et al., 2001; Davidson and Stow,
2005). We have previously demonstrated, in the case of EBV-
and human endogenous retrovirus K (HERV-K-encoded dUT-
Pases, that enzymatic activity is not required for modulating the
immune response (Glaser et al., 2006; Waldman et al., 2008;
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Ariza et al., 2009, 2013; Ariza and Williams, 2011). This find-
ing has now been further confirmed by the data presented in
this study demonstrating that like the human cytomegalovirus
(HCMV)-encoded dUTPase (Caposio et al., 2004), the HHV-6A-
encoded dUTPase lacks functional dUTPase hydrolytic activity.
However, the HHV-6-encoded dUTPase is capable of stimu-
lating DCs and PBMCs through TLR2/TLR1 and induce the
secretion of cytokines. The size and sequence homologies of
the herpesviruses-encoded dUTPase proteins vary greatly; the
EBV-encoded dUTPase is the smallest (278 amino acids) while
the VZV-encoded dUTPase is the largest (396 amino acids).
The greatest identity (26.8%) occurs between the EBV- and
HHV-8-encoded dUTPases, and the least identity (10.9%) occurs
between the EBV- and HHV-6A-encoded dUTPases. While the
crystal structure of several homotrimeric dUTPases, includ-
ing Escherichia coli, human, HERV-K, feline immunodeficiency
virus and equine infection anemia virus, has been determined
(Cedergren-Zeppezauer et al., 1992; Mol et al., 1996; Dauter et al.,
1999; Harris et al., 1999; Prasad et al., 2000), the only structure
of monomeric dUTPases that has been determined is for EBV
(Tarbouriech et al., 2005). Preliminary studies using blast align-
ments and Kyte-Doolittle hydropathy analyses have identified a
region within a β-hairpin loop that is conserved among these
proteins, which may interact with TLR2 and studies are presently
underway to address this possibility.
It has been suggested that the herpesvirus dUTPase gene was
captured from a host followed by gene duplication and gene
fusion (Baldo and McClure, 1999; McGeehan et al., 2001). Over
time, additional residues were lost resulting in the formation of
proteins lacking enzymatic activity but that possess other bio-
logical functions. Analysis of sequence similarities coupled with
structural predictions led Davidson and Stow (2005) to suggest
that several herpesvirus genes, including the UL31, UL82, UL83,
and UL84 genes of HCMV as well as ORF10 and ORF11 of
HHV-8, may have been derived from an ancestral herpesvirus
dUTPase gene. Interestingly, the UL83 gene product pp65, a
structural protein, has been reported to decrease the interferon
response (Browne and Shenk, 2003; Abate et al., 2004) and to
down-regulate MHC class II protein expression (Wiertz et al.,
2007). This phenomenon of an ancestral dUTPase gene con-
tributing to the formation of a protein with novel functions is
not limited to the herpesviruses. The human adenovirus type
9 E4-ORF1 gene, which evolved from an ancestral avian dUT-
Pase (Weiss et al., 1997), encodes for a protein that possesses
oncogenic properties (Weiss et al., 1997), induces cellular glu-
cose uptake (Dhurandhar et al., 2011) and adipogenesis (Rogers
et al., 2008). Likewise, studies by Abergel et al. (1999) suggest
that an ancestral dUTPase gene evolved into the primate CD4
and chemokine receptor interacting region of the human immun-
odeficiency virus glycoprotein 120 (gp120). Gp120 is shed from
the mature virion in vitro, has been detected in the plasma of
patients early during the infection and correlated with higher lev-
els of TNF-α, IL-6, IL-10, INF-α, and IFN-γ (Rychert et al., 2010).
Interestingly, this gp120-mediated process has been suggested to
contribute to the immune dysfunction during early HIV infection
(Rychert et al., 2010) and has been implicated in HIV-1 associated
inflammation (Nazli et al., 2010; Kaushic, 2011; Shah et al., 2011).
Furthermore, the gp120 has been reported to activate TLR2, and
trigger inflammatory cytokine production through NF-κB, sug-
gesting that this is a mechanism by which gp120 could directly
initiate innate immune activation (Nazli et al., 2013). While addi-
tional studies are required to demonstrate that the biological
properties of these proteins are due to the dUTPase motifs, these
results further support the hypothesis that dUTPase proteins,
especially viral-encoded dUTPases, may have undiscovered func-
tions that modulate various physiological processes, including
those involved in host immune responses.
In summary, our results demonstrate that the dUTPases
encoded by several human herpesviruses induced a dose-
dependent increase in the activation of NF-κB and the secretion
of several pro-inflammatory cytokines, which may contribute
to the pathophysiology associated with diseases caused by these
viruses. Interestingly, TLR2 blocking studies revealed that the
enhanced cytokine secretion is herpesviruses-encoded dUTPase-
mediated and TLR2-dependent. More importantly, however, is
that the data reported in this study, as well as our previous
studies on the EBV- and HERV-K-encoded dUTPases (Glaser
et al., 2006; Waldman et al., 2008; Ariza et al., 2009, 2013; Ariza
andWilliams, 2011), demonstrate that some virus-encoded dUT-
Pases possess novel functions as modulators of innate immune
responses through TLR2 leading to the activation of NF-κB
and cytokine/chemokine-receptor signaling pathways, which may
contribute to the inflammatory microenvironment leading to
pathogenesis. Finally, this hypothesis is further supported by the
revelation that some genes containing ancestral dUTPase motifs
encode for proteins that also have immune modulating activities.
These findings suggest that viral-encoded dUTPases may repre-
sent a novel class of proteins that could be used as targets for the
development of novel therapeutics.
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